One candidate for a mesoderm-inducing factor in early amphibian development is activin, a member of the TGF/3 family. Overexpression of a truncated form of an activin receptor Type IIB abolishes activin responsiveness and mesoderm formation in vivo. The Xenopus Type IIA activin receptor XSTK9 differs from the Type IIB receptor by 43 and 25% in extracellular and intracellular domains respectively, suggesting the possibility of different functions in vivo. In this paper, we compare the Type IIA receptor with the Type IIB to test such a possibility. Simple overexpression of the wild-type receptors reveals minimal differences, but experiments with dominant negative mutants of each receptor show qualitatively distinct effects. We show that while truncated (kinase domain-deleted) Type IIB receptors cause axial defects as previously described, truncated type IIA receptors cause formation of secondary axes, similar to those seen by overexpression of truncated receptors for BMP-4, another TGF/3 family member. Furthermore, in animal cap assays, truncated type IIB receptors inhibit induction of all mesodermal markers tested, while truncated type IIA receptors suppress induction only of ventral markers; the anterior/dorsal marker goosecoid is virtually unaffected. The suppression of ventral development by the type IIA truncated receptor suggests either that the truncated Type IIA receptor interferes with ventral BMP pathways, or that activin signaling through the Type IIA receptor is necessary for ventral patterning. 0 1997 Elsevier Science Ireland Ltd. All rights reserved
Introduction
Mesoderm induction in amphibian development occurs during blastula stages, when signals from the vegetal hemisphere of the embryo act on overlying equatorial cells (Nieuwkoop, 1969 ; see reviews by Sive, 1993; Cornell and Kimelman, 1994; Smith, 1995) . One of the most intriguing aspects of mesoderm induction is that the process involves transmission of position& information. Dorsal vegetal blastomeres induce responding animal pole cells to form predominantly dorsal cell types, whereas ventral vegetal cells induce ventral tissue (Boterenbrood and Nieuwkoop, 1973) . There are also differences in the responsiveness of animal pole cells that predispose them to dorsal or ventral fates (Sokol and Melton, 1991) .
of Development 61 ( 1997) tive ectodermal tissue and also impose pattern on these responding cells in a dose-dependent fashion. In the case of activin, another TGF@ family member, high concentrations induce dorsal cell types such as notochord and muscle, and activate dorsal-specific genes such as goosecoid, whereas low concentrations induce ventral cell types such as mesenchyme and blood and activate posteriorlyexpressed genes such as Xhox.? (Green et al., 1990; Green et al., 1992) . The differential induction of different tissue types occurs at sharp thresholds of activin concentration.
These results raise the possibility that pattern formation in the Xenop~s embryo occurs in response to a gradient of activin protein, in the same way that a gradient of the related factor Decapentaplegic (Dpp) is thought to specify pattern in the dorso-ventral axis of Drosophila (Ferguson and Anderson, 1992) . They raise the question of how cells might distinguish between small differences in external inducing factor concentration to produce sharp changes in gene activity. In Drosophila, differential effects of Dpp concentration are thought to be mediated by two receptors of differing affinity (Brummel et al., 1994; Nellen et al., 1994; Penton et al., 1994) . Thus, a low-affinity receptor, sax, is activated in the small dorsal region where Dpp is at high concentrations whereas a high-affinity receptor, tkv, is activated over a broader dorsal-to-lateral region that includes high and low Dpp concentrations. Although Dpp is more homologous to BMP4 than to activin (see Holley et al., 1995) , the demonstrated doseresponse effects of activin raise the question of whether two or more activin receptors likewise distinguish concentrations of a spatially graded ligand. Gurdon and colleagues (Gurdon et al., 1994; Gurdon et al., 1995) have shown that activin can indeed act in the morphogen-like way.
Cross-linking studies in mammalian cells reveal two classes of cell-surface activin receptor, with relative molecular masses of 50-60 and 70-80 x lo3 (see Hino et al., 1989) . By analogy with the related TGFP receptors , these are termed respectively the Type I and Type II activin receptors (Attisano et al., 1992) . Type I activin receptors were first cloned by Attisano et al. (1993) and characterized as transmembrane serine/threonine kinases. Type II activin receptors (Mathews and Vale, 1991; Attisano et al., 1992; Mathews et al., 1992; Massague et al., 1994) are also transmembrane serine/threonine kinases, and they fall into two subclasses: ActR-II (Mathews et al., 1992) and ActR-IIB (Attisano et al., 1992) . In the mouse, this diversity of activin receptor structure is increased by alternative splicing of the ActR-IIB gene. This generates five different forms of type II activin receptor that differ in ligand binding affinity, or cytoplasmic domain structure, or both (Attisano et al., 1992) .
A number of different Type II activin receptors have been cloned in Xenopus, including representatives of both the Type II (which we shall refer to as Type IIA for clarity) and Type IIB classes Nishimatsu et al., 1992a) . If, as with Drosophila Dpp receptors, these different activin receptor classes transduce distinct signals, it is possible that in Xenopus they would respond to an activin gradient in the embryo by generating different mesodermal tissue types. To investigate this possibility, we have compared the effects on Xenopus development of two different Xenopus activin receptors: XSTK9 (Nishimatsu et al., 1992a; Nishimatsu et al., 1992b) , a representative of the Type IIA class, and XARl , a type IIB. In one set of experiments, we have overexpressed the wildtype receptors in whole embryos and in animal caps. In a . and vegetal poles (Vg). Yeast tRNA (tRNA) was used as a negative control for protection. Pigment differences were used to define dorsal (DMz), lateral (LMz) and ventral (VMz) marginal zones. To confirm these assignments, additional explants were allowed to develop to stage 10, when they were analyzed for expression of goosecoid. These results were observed in three separate experiments. Samples were co-protected with EFlor to control for amount of RNA loaded. The difference in appearance of EFlor between the XSTK9 and goosecoid protections results from the use of RNAase A with XSTK9.
second, we inject RNA encoding truncated forms of the receptor, as previously described for XARl by HemmatiBrivanlou and Melton (1992) . Simple overexpression of the wild-type receptors does not reveal any difference in their effects, but experiments with the two truncated receptors indicate that they may have different functions during development. To discover whether XSTK9 and XARl have different functions during development, RNAs encoding the two proteins were injected into ventral/animal blastomeres of Xenopus embryos at the 16-cell stage, and the effects were recorded at the tadpole stage. Injecting 2 ng RNA per blastomere gave the maximum response, although characteristic perturbations of development occurred at doses as low as 0.2 ng. Effects were stronger when animal blastomeres rather than vegetal blastomeres were injected (data not shown). Control embryos were either uninjected, injected with ASTK-7, a truncated form of XSTK9 lacking a substantial portion of the transmembrane domain and beyond (see Fig. l ), or injected with XIDM, a non-functional mutant of a Xenopus transcription factor, Xid (see Experimental procedures for details).
Results

Fig
Injection of either XSTK9 or XARl RNA into a single animal blastomere resulted in the formation of tail-like protrusions (Fig. 3B,C) , consistent with previous reports by Hemmati-Brivanlou et al. (1992) . The frequency of 'tails' generated by injection of XSTK9 RNA was slightly higher than that obtained with XARl (Fig. 3A) , and the tails formed in response to XSTK9 tended to be larger than those induced by XARl. Tails were also formed in response to injection of an independent clone of the Type IIB receptor, xActRIIB RNA (data not shown; see Experimental procedures for clone details). In embryos which lacked an additional tail, patches of brown pigment were frequently observed on the body wall, either at the base of the tail or ventrolaterally. This may represent a more subtle form of the tail phenotype, because embryos with tails have similar pigmented regions (see Fig. 3C ). Histological analysis of embryos with an additional tail revealed a pigmented region resembling gut endoderm close to an epidermal protrusion which contained neural cells, often associated with a block of muscle ( Fig. 3D-G) . Notochord was not seen in these regions. When XSTK9 was injected into a ventral animal blastomere, the tail-like protrusions usually originated from the ventral or lateral regions; however, when XSTK9 was injected on the dorsal side, the tails often formed on the dorsal side of the embryo, frequently just behind the head (data not shown).
Animal caps derived from embryos which received injections of XSTK9, XARl (Fig. 4C,D It shows the means f SEM for four experiments, with a total of 98-l 10 embryos injected for each condition. As controls, 1 ng of the XIDM or ASTK-7 was injected, to produce similar molar amounts of RNA. The graph shows results obtained after injection of 2 ng of ASTK-7, which gave similar results to the other controls. Scoring criteria: 'Normal/slightly small' includes some embryos which were slightly short or had slightly small eyes. This small subjective variation was also present in uninjected embryos. 'Non-specific abnormalities' includes major abnormalities found in both control and receptor-injected embryos, such as small eyes, truncated heads or tails, and spina bifida. 'Tails' describes embryos with small tail-like protrusions. 'Other specific abnormalities'.
only seen in receptor injected embryos, include brown pigment patches, usually at the base of the tail, small tail-like blebs, and fine 'axial' lines of pigment running anteriorly from the region of the tail. 4A,B) (see Symes and Smith, 1987) . Histological analysis of such explants, made when control embryos had reached the tadpole stage, revealed mesenchyme, mesothelium and blood-like cells ( Fig. 4G,H ). There were also collections of pigmented endodermal cells similar to those seen in the whole embryos, small groups of muscle cells, pigment cells, and epidermal protrusions containing neural tissue.
No difference was observed between caps derived from XARl-injected animal caps and those which received XSTKB RNA. No notochord was seen in either case (see Fig. 4F for comparison with effects of induction using soluble activin).
RNase protection analysis of animal caps assayed at stage 12 (late gastrula) showed that XSTK9 and XARl both activated the ventral-specific mesodermal gene Xwnt-8 as well as Xbra, which is expressed throughout the marginal zone (Fig. 41 ). By contrast, the level of induction of muscle-specific actin, analyzed at stage 16-18 (neurula), was low when compared with levels in intact control embryos (Fig. 45) . Very low levels of gsc expression were detectable in one out of three experiments following injection of each receptor and analysis at stage 12 (not shown). There was no effect of receptor RNA injection on either noggin or N-CAM expression (Fig. 41) . Additional experiments showed that injection of XSTKB and xActRIIB RNA both increased levels of a posteriorspecific gene, Xhox3 (Ruiz i Altaba and Melton, 1989) (not shown).
Effects of truncated activin receptors on embryos
The experiments described above revealed no differences between the functions of XSTK9 and XARl. To obtain more information about their actions we therefore attempted to block their effects by using truncated mutant receptors to interfere with wild type receptor function. Such 'kinase-less' receptor mutants have been shown to act as dominant negative reagents in a number of contexts (e.g. Amaya et al., 1991; Hemmati-Brivanlou and Melton, 1992) . Polymerase chain reaction (PCR) was used to generate truncated versions of XSTKB which lacked the serine/threonine kinase domain, but retained 10 intracellular amino acids (ASTK + 10) (Fig. 1) . These enabled us to make direct comparisons with the equivalent XARl mutant, AlXARl . When injected on either the dorsal or the ventral side of 1-4 cell stage embryos, the two truncated receptor constructs had dramatically different effects. As previously reported by Hemmati-Brivanlou and Melton (1992) , AlXARl causes axial defects. We very occasionally observed the 'bubble embryo' phenotype that lacks all semblance of a dorsal axis as reported to occur in 25% of injected embryos . This phenotype occurs more frequently when all four cells of a four-celled embryo are injected (Ali Hemmati-Brivanlou, personal communication), but in our experience this phenotype was rare (less than 5% of injected embryos). Most often, we observed that AlXARl-injected embryos had truncated axes and lacked dorsoanterior structures, with reduced or absent eyes and heads (Fig. 5B) .
By contrast, ASTK + lo-injected embryos developed duplicated axes at reproducibly high frequencies (Fig.  5C ). We observed some degree of axis duplication with a frequency of 41%, n = 95. The duplicated axes were of varying degrees of completeness, and sometimes contained anterior structures such as cement glands (1 l%), and, less frequently, eyes (5%) (Fig. 5D ). Duplicated axes were more frequently observed when ASTK + 10 injection was targeted to the ventral rather than the dorsal blastomeres of a 4-cell stage embryo (80% axis duplication versus 41% when not targeted). Similar results were observed when injections were performed at the 16-cell stage (not shown). As observed with injections at the 4-cell stage, axis duplication occurred more frequently when injections were made into ventral cells (66%; n = 128) than they did following injections into dorsal blastomeres (1%; II = 127). There was little difference in the frequency of axis duplication following injection into ventral vegetal blastomeres (55%; II = 65) versus ventral animal blastomeres (48%; n = 63). The axis duplications observed appear similar to those generated by a number of other treatments which cause axis duplication, including injection of truncated BMP4 receptors (see Discussion).
Both ASTK + 10 and AlXARl mutant phenotypes could be 'rescued' by co-injecting the corresponding wild-type receptors at l/20 the concentration of the mutant receptor injected, e.g. 0.05 ng of wild-type construct per 1 .O ng mutant receptor (not shown). This is consistent with the small amount of XARl needed to rescue AlXARl as reported by Hemmati-Brivanlou et al. (1992) .
Morphological and histological effects of truncated activin receptors in activin-induced animal cap explants
For a precise idea of the effect of the truncated receptors on the activin response we injected RNA for the constructs into animal hemispheres at the l-2 cell stage, dissected animal caps at blastula stage and allowed them to develop with or without addition of activin. Different effects of the two truncated receptors were reflected in the appearance of activin treated animal caps. Activin A treatment of control caps caused a dramatic elongation (compare Fig. 6A,B ) (see Symes and Smith, 1987) , which was inhibited by the presence of AlXARl RNA (Fig. 6F ) (see also Hemmati-Brivanlou and Melton, 1992) . By contrast, caps derived from embryos which had received injections of ASTK + 10 were much less strongly inhibited, and underwent greater elongation (Fig. 6D) , although this was not as extensive as seen in control caps. The difference in elongation between caps injected with AlXARl and those injected with ASTK + 10 was observed through a range of amount of RNA injected (0.2-5 ng), with AlXARl in some experiments able to suppress elongation completely at moderate doses when ASTK + 10 was unable to do so even at RNA levels approaching toxicity (data not shown).
In the absence of additional factors, injection of either truncated receptor induced NCAM expression (Fig. 7A ) and neural differentiation (Fig. 6K,M ) in explants. This had been previously shown for AIXARI . As well as causing an induction of NCAM, injection of either truncated activin receptor RNA also brought about an increase in levels of gsc at neurula stages (Fig. 7A ). This was a late effect, however, that was not observed at gastrula stages (not shown). Little effect on noggin expression was observed in response to either truncated receptor, and neither induced expression of Xbru (Fig. 7A) , Xwnt-8, or Xh&' (not shown). By the neurula stage, caps from embryos injected with AlXARl and with ASTK + 10 had become irregular in shape (Fig. 6C,E) and N-CAM transcripts were present (Fig. 7A) . By tadpole stages, cement glands were visible (Fig. 6H) .
Histological analysis of control-injected caps treated with activin A revealed induction of a mixture of mesodermal and neural cell types, including notochord and muscle ( Fig. 65; see also Fig. 4F ). Animal caps injected with either of the truncated receptors and treated with activin formed neural tissue and cement gland (Fig.  6L,N) . However, while the presence of AlXARl RNA substantially inhibited mesoderm formation in response to activin (Fig. 6N) , treatment of caps injected with ASTK + 10 RNA led to the formation of large amounts of notochord, together with a little muscle (Fig. 6L) .
Effects of truncated activin receptors on mesodermal markers in activin-induced animal cap explants
For analysis of the molecular effects of the truncated receptors, we examined the expression of a number of mesodermal genes in animal cap explants dissected from injected embryos and compared the abilities of the truncated receptors to inhibit or modulate the effects of activin. Treatment of control caps with activin A induces the expression of gsc, Xwnt8, Xbra, muscle actin, and, although weakly, noggin (Fig. 7B,C) . As reported, injection of RNA encoding AlXARl into Xenopus embryos blocks the ability of activin A to induce expression of gsc and Xbra at gastrula stages and expression of muscle-specific actin at neurula stages (Hemmati-Brivanlou et al., 1992) (see also Fig. 7B,C) . We also find induction of the ventrolateral mesodermal marker Xwnt-8 is also blocked at the late gastrula stage by AlXARl (Fig. 7B) . Quantitation of three experiments reveals that expression of these genes is inhibited by approximately 90% compared to control levels.
By contrast, ASTK + 10 was able to block substantially the induction of only two of these mesodermal markers. As illustrated in Fig. 7B ,C, induction of Xwnt8 was inhibited to approximately 80% and actin to approximately 8.5%. However, gsc levels, assessed at late gastrula stages 12-12.5, were unaffected in each of four experiments, and Xbra expression was reduced by only about 15% (Fig.   7B ). Two experiments analyzed at stage 11 did reveal some inhibition of gsc expression by ASTK + 10 (not shown). The weak induction of noggin expression by activin A was reduced to control levels at gastrula stages in some experiments by AlXARl but in most cases was unaffected by ASTK + 10; an exception is shown in Fig.  7B . Conversely, the induction of NCAM and gsc at neurula stages by both truncated receptors was largely unaffected by treatment with activin A (not shown).
These results indicate that AlXARl causes a more complete suppression of mesodermal markers than does ASTK + 10; in particular, ASTK + 10 is a poor inhibitor of gsc expression. It is unlikely that this difference is due to poor stability or translatability of ASTK + 10 RNA compared to AlXARl. Firstly, activation of gsc requires high concentrations of activin (Green et al., 1992; Gurdon, et al., 1994) , and expression of this gene might therefore be expected to be the most sensitive to inhibition of activin signaling, rather than the least. Secondly, ASTK + 10 is as effective as AlXARl in inhibiting expression of Xwnt-8 and muscle-specific actin (Fig. 7B,C) , and the two truncated receptors are also equally effective at inducing N-CAM expression at neurula stages (Fig. 7A) . These considerations suggest that the effects of AlXARl and ASTK + 10 are qualitatively different. Nevertheless, to control for the possibility that ASTK + 10 RNA is unstable or poorly translated, we injected different doses of AlXARl RNA (0.15-5.0 ng) into Xenopus eggs and monitored inhibition of activin responses in animal caps derived from these embryos compared with those derived from ASTK + lo-injected eggs. If AlXARl and ASTK + 10 in fact behave similarly, and the poor inhibition of gsc, but not of Xwnt8, is due to poor expression of ASTK + 10, then low doses of AlXARl should elicit a similar pattern of response; gsc expression should occur while expression of other genes such as Xbra and Xwnt8 should still be suppressed. Fig. 8 shows that as the amount of injected AlXARl decreases, the three early mesoderm markers gsc, Xwnt8, and Xbra increase in concert. At no dose does gsc expression remain high while Xbra and Xwnt 8 are suppressed. Thus the selective?xpression of gsc is seen only with injection of ASTK + 10, arguing that AlXARl and ASTK + 10 exert qualitatively distinct effects.
Discussion
Two classes of type II activin receptor are expressed in the early Xenopus embryo: Type IIA (also known as Type II) and Type IIB. Both are expressed ubiquitously during blastula stages (Fig. 2) . This paper studies the effects of a Type IIA activin receptor (XSTK9) on Xenopus development, and compares the results with those caused by a Type IIB receptor (XARl).
Overexpression of full-length receptors
In many respects the phenotypes generated by overexpression of the two genes are similar. Overexpression of either receptor on the ventral side of Xenopus embryos causes, with similar frequencies, formation of additional tail-like structures. Similar results have been reported for the overexpression of type II activin receptors (HemmatiBrivanlou et al., 1992; Mathews et al., 1992; Nishimatsu et al., 1992b) although some reports describe tail-like protrusions as 'posterior axis duplications' (Mathews et al., 1992; Nishimatsu et al., 1992b) . We were surprised to observe that injection of activin Type IIA receptor RNA into dorsal blastomeres caused tail-like structures to protrude from the head; we had predicted that injection of either receptor into dorsal blastomeres might increase the size of or duplicate anterior structures, since injection of type IIB activin receptor RNA into embryos causes animal caps cut from these embryos to be sensitized to activin (Mathews et al., 1992) and high effective activin dose should induce dorsoanterior mesoderm (Green et al., 1994) .
In further experiments, activin receptors were overexpressed in isolated animal caps, and again no significant differences were observed between the Type IIA and the Type IIB receptors. Thus caps derived from embryos which have received injections of XSTK9 or XARl RNA both undergo a small amount of elongation and subsequently differentiate as mesenchyme, mesothelium and blood-like cells. There are also small groups of muscle cells, and epidermal protrusions containing neural tissue. RNase protection analysis reveals that the mesoderm-specific genes Xwnt-8, Xhox3 and Xbra are induced to high levels, muscle-specific actin is induced to low levels, but gsc induction is not observed. No induction of noggin or N-CAM was detected by RNase protection although small numbers of neural cells could be recognized histologically. Overall, these results indicate that overexpression of Type IIA or Type IIB receptors causes formation of ventral and lateral mesodermal cell types, as seen in response to low doses of exogenous activin (Green et al., 1990) .
Effects of truncated activin receptors on ernbvos
To investigate potential differences in the functions of the Type IIA and Type IIB receptors further, we injected RNA encoding truncated forms of the receptors. Injecting truncated Type IIB receptor (AlXARl) caused disruptions of dorsal and anterior tissue, although it only rarely abolished mesoderm formation and axial structures altogether. Injecting all four cells of the four cell stage embryo appears to increase the mesoderm-less 'bubble embryo' phenotype described by Hemmati-Brivanlou and Melton (1992) but in our hands this rarely approaches 25% of injected embryos. In marked contrast, injecting RNA encoding a truncated Type IIA activin receptor (ASTK + 10) results in duplicated axes. Axis duplication is never seen with AlXARl. and this observation is an 
Effects of truncated activin receptors on animal caps
Experiments involving expression of truncated receptors in animal caps are consistent with the phenotypes of the injected whole embryos. In the first set of experiments, truncated XSTK9 (denoted ASTK + 10) or XARl (AlXARl) RNA was injected into Xenopus embryos and animal caps were dissected at the mid-blastula stage. As reported by Hemmati-Brivanlou and Melton (1992) , AlXARl RNA injection caused animal caps to become misshapen, to express N-CAM and to differentiate as neural tissue. Our data show that ASTK + 10 RNA has the same effect, indicating that in this respect the effects of the two truncated receptors are similar.
Animal caps derived from embryos injected with RNA encoding AlXARl are unable to express normal levels of noggin, Xwnt-8, Xbra, muscle-specific actin or (when assessed at gastrula stages) gsc in response to activin (Fig. 7B,C) . By contrast, ASTK + 10 inhibits gsc and, to a lesser extent, Xbra, poorly. Titration of injection dose against activin inducibility of a panel of genes shows that the differences between the effects of the two truncated receptors cannot be attributed to differences in efficiency of expression. Differences between ASTK + 10 and AlXARl are also apparent after histological analysis, where activin treatment of animal caps expressing AlXARl fails to induce mesoderm and the cells form neural tissue with or without activin. By contrast, activin treatment of caps expressing ASTK + 10 causes the formation of large amounts of notochord in addition to neural tissue. Together, these results suggest that ASTK + 10 inhibits induction only of posterior and ventral mesoderm, while AlXARl prevents formation of all mesodermal cell types. The partial block of Xbra expression by ASTK + 10 may reflect the fact that Xbra is expressed in two domains: posterior mesoderm and notochord. The fact that activin treatment of caps expres- sing ASTK + 10 causes formation of notochord as well as neural tissue suggests that it is the posterior expression domain that is inhibited by this construct.
Thresholds and specijkities of truncated receptors
The different effects of AlXARl and ASTK + 10 point to functional differences between the two type II activin receptors. We note that the effects of ASTK + 10, both in whole embryos and in animal caps, are similar to those of truncated Type I or Type II BMP-4 receptors (Graff et al., 1994; Suzuki et al., 1994 : Maeno et al., 1994 Ishikawa et al., 1995) . This suggests that ASTK + 10 blocks BMP-4 signaling as well as activin signaling, and that inhibition of the former is more efficient than that of the latter. Such an inhibition could occur directly, by interference with endogenous type I BMP-4 receptors, or indirectly, by interference with endogenous type I activin receptors that are somehow required for functioning of BMP-4 pathways. Wilson and Hemmati-Brivanlou (1995) have recently shown that BMP-4 signaling is also blocked by A lXAR1, but since this truncated receptor inhibits formation of dorsal tissues (this paper and Hemmati-Brivanlou and Melton, 1992), inhibition of activin signaling in this case must be more efficient than inhibition of BMP-4. One mechanism by which the truncated receptors might interfere with signaling in two different pathways is through heterodimer formation with different type I receptors (Ebner et al., 1993 ; see also Massague et al., 1994) .
Together, these results are consistent with the idea that both activin-and BMP-like signaling is involved in patterning the mesoderm of Xenopus, and they indicate that truncated Type IIA and Type IIB receptors allow us to distinguish between these two signaling pathways. Thus, blocking signaling by a Type IIA receptor such as XSTKB allows the Type IIB pathway to specify secondary axes, while blocking signaling by a Type IIB, such as XARl, permits signaling only through the Type IIA pathway, and this specifies predominantly ventral mesoderm through the BMP4 pathway. The experiments also offer an explanation as to why it is difficult to block mesoderm formation completely by overexpression of just one truncated receptor. The existence of two overlapping receptor systems, one more responsive to activin than to BMP4, and one more responsive to BMP-4 than to activin, may be involved in the interpretation of activin-and BMP-4-like gradients in the early embryo. A complete understanding of this issue will involve a detailed analysis of activin receptor affinities in vivo.
Experimental procedures
Embryos and RNA injections
Xenopus embryos were obtained by artificial fertilization as described by Smith and Slack (1983) . They were dejellied with 2% cysteine hydrochloride (pH 7.8-8.1) and staged according to Nieuwkoop and Faber (1994) . Embryos were allowed to develop in 10% normal amphibian medium (NAM) (Slack, 1984) until they reached the appropriate stage for RNA injection, when they were transferred to 75% NAM containing 4% Ficoll Type 400 (Sigma). RNA was injected using an air driven system as described by Smith (1993) . For injections at the one-cell stage, approximately 10 nl RNA was injected onto the animal hemisphere.
These embryos were allowed to develop to stage 8 (mid-blastula) before being transferred to 75% NAM for dissection of animal caps. Caps were cultured as pairs in 75% NAM containing 0.1% bovine serum albumin (BSA) with or without growth factors as appropriate. Embryos injected at the 16-cell stage received approximately 4 nl RNA per blastomere. The ventral side of embryos was identified by its heavier pigmentation. After injection embryos were cultured for at least 1 h before being transferred to 10% NAM/4% Ficoll to continue development.
In vitro transcription and translation
Clones used to generate RNA for microinjection were as follows: (1) cDNA encoding XSTK9 was a gift from Naoto Ueno (see Nishimatsu et al., 1992a; Nishimatsu et al., 1992b) . This was inserted into the vector pSP64T (Krieg and Melton, 1984) to generate pSP64T-XSTK9.
(2) Truncated versions of pSP64T-XSTK9 were generated using the PCR. Most experiments used a construct (ASTK + 10) in which the serine/threonine kinase domain was deleted but which retained 10 amino acids of the cytoplasmic domain followed by a stop codon (see Fig.  1 ). Additional constructs retained five or 30 intracellular amino acids. As a control, one construct was made where fhe truncation occurred seven amino acids before the start of the cytoplasmic domain (ASTK-7). The product of such a construct would be expected not to remain membrane anchored, and therefore should not act as a dominant negative. The coding region of ASTK + 10 was sequenced and no difference from XSTK9 was noted. (3) Expression constructs encoding XARI ) and AlXARl (Hemmati-Brivanlou and Melton, 1992), were gifts of Ali Hemmati-Brivanlou and Doug Melton. (4) cDNA encoding xActRIIB (Mathews et al., 1992) cloned into pSP64T, was a gift of Chris Kintner. (5) A clone encoding a non-functional mutated version of Xenopus ID transcription factor, XIDM, was a gift of Robert Wilson and Tim Mohun (NIMR) .
RNA for microinjection was transcribed as described by Smith (1993) . In vitro translation of the activin receptor constructs, using rabbit reticulocyte lysate (Promega) and ["'Slmethionine, was carried out according to the manufacturer's directions. Translation products were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and visualized by autoradiography.
Truncated and wild type RNA's of both receptor types translated with high efficiency, although all ran with slightly lower mobility than expected on SDS-PAGE.
Mesodenn-inducing factors
Recombinant human activin A was purified virtually to homogeneity from medium conditioned by CHO cells transfected with the human inhibin @A gene (gift of Gordon Wong, Genetics Institute). Experiments were also done using Xenopus activin @a made in a baculovirus system (gift of Cord Dohrman and Douglas Melton, Harvard U.). In some early experiments, crude conditioned medium was used. In all cases, activin effects were identical. Activity of the factors was assayed by the animal cap assay (Cooke et al., 1987) , with 1 unit/ml being defined as the minimum concentration necessary for induction to occur. Activin A was used at a concentration of 10 U/ml.
RNA extraction and RNase protections
RNA was extracted as described by Sargent et al. (1986) except that the first phenol/chloroform extraction was carried out in two separate steps. The final LiCl precipitation step was omitted. RNA pellets were dissolved in water and used directly for hybridization.
[32P]UTP labeled probes were synthesized as described by Krieg and Melton (1987) , except that DNase and phenol/chloroform steps were omitted and the probe was purified directly from a 6% acrylamide gel after synthesis. Hybridization of mixed probes with RNA samples was essentially as described by Krieg and Melton (1987) , but in a volume of 40 ~1 at 50°C for 16-20 h. Unhybridized RNA was digested with 10 U/ ml RNAase Tl (Calbiochem) or with RNase Tl and 37.5 pglml RNAase A in the case of XSTK9 (to avoid detection of the closely related XAR7) (Kondo et al., 1991) . Unless stated otherwise, RNA from 10 animal caps was analyzed in most experiments, except for actin, where RNA from 3-4 caps was used. Protected fragments were analyzed on a 6% sequencing gel. Autoradiography was with preflashed Kodak X-Omat film. A PhosphorImager (Molecular Dynamics) was used for band quantitation.
Probes used were as in Green et al. (1992) with the addition of the following: Xhox3 (see Saha and Grainger, 1992) . An N-CAM probe was prepared from the clone pN1, an EcoRI-PvuII subclone of Nl cDNA (Kintner and Melton, 1987) as used by Dixon and Kintner (1989) . The template was linearized with Hind111 to give a predicted probe length of 563 nucleotides, but premature termination resulted in a probe of about 215 nucleotides. An XSTK9 probe was constructed from an XSTKB cDNA in Bluescript SK(-) (Stratagene). Sequence between the EspI site in the 3' untranslated region and the downstream XhoI site in the polylinker was removed, and the template was linearized with AvaII. Predicted probe length is 400 nucleotides, protected fragment is 370 nucleotides.
Histology
Specimens were fixed and sectioned as described by Green et al. (1990) . Sections (7 pm) were stained by the Feulgen /Light Green/Orange G technique as described by Smith (1993) and cell types were recognized according to the criteria described by Green et al. (1990) .
